As Zika virus outbreaks continue to rage in South and Central America, lapping at US borders, scientists are making significant strides toward an effective vaccine.
Two types of experimental Zika vaccines, a DNA vaccine and an inactivated virus vaccine, were each able to completely protect mice with one dose, researchers report Tuesday in Nature. The animal data—the first to be published for Zika vaccines—follows news last week that the Food and Drug Administration gave two companies the green light to test another Zika DNA vaccine in humans. The companies, not associated with the researchers behind today’s study, reported that they have done similar animal studies with their vaccine, but they didn’t publish the results.
With today’s animal data, researchers are hopeful about the fate of the vaccines. “The protection was striking,” Dan Barouch, a study coauthor and vaccine researcher at Harvard Medical School, said in a press briefing. “Of course we need to be cautious about extrapolating results from mice into humans,” he noted, but the strength of the findings “certainly raise optimism” that we’re on our way to a safe and effective vaccine.
No comments:
Post a Comment